Keyphrases
COVID-19
100%
Breast Cancer
65%
Academic Medicine
62%
Well-being
62%
Diffusion-weighted Imaging
59%
High Spatial Resolution
59%
Method Comparison
59%
Echo-planar Imaging
59%
Breast MRI
59%
Lived Experience
59%
Intersectional Identities
59%
Gender Differences
59%
I-SPY
59%
Pandemic Experience
59%
Anticancer Immune Response
59%
Neoadjuvant Therapy
59%
Confidence Interval
59%
Frontline Employees
59%
COVID-19 Pandemic
59%
Resilience
59%
Multi-feature
59%
Workplace Well-being
59%
MRI Results
59%
Ultrasound Findings
59%
COVID-19 Vaccine
59%
Lesion Enhancement
59%
Diagnostic Challenge
59%
Index Lesion
59%
Same-day
59%
Contrast-enhanced Mammography
59%
COVID-19 Vaccination
59%
Oncology Patients
59%
Metastasis
59%
Lymphadenopathy
59%
Axillary Lymphadenopathy
59%
Multi-slice
35%
Work-family Conflict
32%
COVID-19 Vaccine Trials
29%
Reactive Lymphadenopathy
29%
Radiological Diagnosis
29%
Unnecessary Biopsy
29%
Adenopathy
29%
Vaccination
29%
Lymph Node Biopsy
29%
Axillary Swelling
29%
Human Epidermal Growth Factor Receptor 2 (HER2)
25%
Image Quality
23%
Caregivers
23%
Multiple Intersections
19%
Imaging Methods
17%
Medicine and Dentistry
COVID-19
74%
Biopsy Technique
74%
Breast Cancer
65%
Magnetic Resonance Imaging of Breast
59%
Histopathology
59%
Diffusion MRI
59%
Mammography
59%
Echo Planar Imaging
59%
Academic Medicine
59%
Personal Experience
59%
Neoadjuvant Therapy
59%
Magnetic Resonance Imaging
59%
COVID-19 Vaccine
59%
Lymphadenopathy
59%
Epidermal Growth Factor Receptor 2
47%
Gamma Urogastrone
47%
Hormone Receptor
47%
Malignant Neoplasm
30%
COVID-19 Vaccination
29%
Metastatic Carcinoma
29%
Image Quality
23%
Medicine
23%
Retrospective Study
18%
Axillary Lymphadenopathy
14%
Lymph Node Biopsy
14%
Arm
14%
Radiodiagnosis
14%
Physical Examination
14%
Contralateral
11%
Dynamic Contrast-Enhanced MRI
11%
Breast Tumor
11%
Morphology
11%
Neoplasm
11%
Logistic Regression Analysis
11%
Neoadjuvant Chemotherapy
11%
Burnout
11%
Public Health
11%
Family Stress
11%
Mixed-Method Research
11%
Family Conflict
11%
Intraductal Carcinoma
6%
Sensitivity and Specificity
6%
False Negative Result
6%
False Positive Result
6%
Diagnostic Performance
6%
Cancer
6%
Treatment Response
5%
Clinical Trial
5%
Prospective Study
5%
Likert Scale
5%
